Stephen Friend just might revolutionize the pharmaceutical industry. After founding Rosetta Inpharmatics, Stephen served as Merck's senior vice president of cancer research. In 2009, he left Merck to create Sage Bionetworks, a nonprofit biomedical research organization. From there, Stephen hopes to create a commons for commercial biomedical researchers.
Visit : www.geneticalliance.org/